Beneski Benjamin Machinas, SVP and Chief Technical Officer at Allogene Therapeutics ($ALLO), sold shares on the open market four times in the last year, totaling about $43,400. His most recent sale occurred on March 2, 2026. These sales rank 10,536th among 11,678 individual insiders, where the average is 8.6 million dollars across 6.4 transactions. He made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | Allogene Therapeutics, Inc. | $ALLO | Beneski Benjamin Machinas | SVP, Chief Technical Officer | S | Common Stock | 2867 | $2.50 | 195,338.0000 | 224,730,144 | 1.45% | 0.00% |
| March 16, 2026 | Allogene Therapeutics, Inc. | $ALLO | Beneski Benjamin Machinas | SVP, Chief Technical Officer | S | Common Stock | 4835 | $2.47 | 198,205.0000 | 224,730,144 | 2.38% | 0.00% |
| March 2, 2026 | Allogene Therapeutics, Inc. | $ALLO | Beneski Benjamin Machinas | SVP, Chief Technical Officer | S | Common Stock | 7132 | $2.60 | 203,040.0000 | 224,730,144 | 3.39% | 0.00% |
| Feb. 2, 2026 | Allogene Therapeutics, Inc. | $ALLO | Beneski Benjamin Machinas | SVP, Chief Technical Officer | S | Common Stock | 7549 | $1.73 | 210,172.0000 | 224,730,144 | 3.47% | 0.00% |
| Feb. 2, 2026 | Allogene Therapeutics, Inc. | $ALLO | Beneski Benjamin Machinas | SVP, Chief Technical Officer | A | Stock Option (Right to buy) | 373757 | $0.00 | 373,757.0000 | 224,730,144 | 9999.99% | 0.17% |
| Feb. 2, 2026 | Allogene Therapeutics, Inc. | $ALLO | Beneski Benjamin Machinas | SVP, Chief Technical Officer | A | Restricted Stock Unit | 105720 | $0.00 | 105,720.0000 | 224,730,144 | 9999.99% | 0.05% |
| Nov. 17, 2025 | Allogene Therapeutics, Inc. | $ALLO | Beneski Benjamin Machinas | SVP, Chief Technical Officer | S | Common Stock | 786 | $1.22 | 217,721.0000 | 224,730,144 | 0.36% | 0.00% |
| March 14, 2025 | Allogene Therapeutics, Inc. | $ALLO | Beneski Benjamin Machinas | SVP, Chief Technical Officer | S | Common Stock | 5488 | $1.98 | 218,507.0000 | 217,264,738 | 2.45% | 0.00% |
| March 1, 2025 | Allogene Therapeutics, Inc. | $ALLO | Beneski Benjamin Machinas | SVP, Chief Technical Officer | A | Stock Option (Right to buy) | 112339 | $0.00 | 112,339.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2025 | Allogene Therapeutics, Inc. | $ALLO | Beneski Benjamin Machinas | SVP, Chief Technical Officer | A | Common Stock | 31755 | $0.00 | 223,995.0000 | 0 | 16.52% | 0.00% |